Royal Olympic Hotel
Athens, 15-16/3/2019

IASIS PHARMA participated as a Gold Sponsor in the 24th Greek Conference for Helicobacter pylori and Other Infections of the Digestive Tract. The conference was organized by the Greek Society of Gastroenterology and the Hellenic Society for Infectious Diseases, at Royal Olympic Hotel Athens, 15-16 March 2019.

IASIS PHARMA presented mastihatherapy® caps, the unique traditional herbal medicinal product containing 350mg of pure Chios Mastic (Pistacia lentiscus var. chia), for the treatment of functional dyspepsia. HCPs showed special interest for this herbal medicinal product (EMA, 2015), known to humanity for over 2.500 years with several historical reports, but also many scientific studies that are still being carried out. One of the most recent study is the “Development and application of HPLC-DAD and HPTLC methods for quality control of Chios Mastic and Products”.

Specialists were also informed about IASIS PHARMA participation to Chios Mastiha Research and Development Center (Kallimasia, isle of Chios, Greece) and IASIS PHARMA brand new, state-of-the-art Manufacturing Facilities, Distribution Center and R&D Center, situated in Koropi, Attiki.

During the Conference, a round table discussion was sponsored by IASIS PHARMA, under the title “Chios Mastic, the Newest Data”, which gathered the interest of many HCPs who attended lectures carried out from expert speakers from the University of Athens.